CJC-1295: What It Is and How Access Works
A neutral explainer on what CJC-1295 is, its status as a prescription GH-secretagogue compound, and how legitimate access works through a licensed provider.
By The Peptide Samples Desk · 6 min read · Updated 2026-06-14
Find your match.
Answer two quick questions — we'll point you to the gummy that fits and this week's best deal.
CJC-1295 is a GH-secretagogue peptide commonly discussed alongside ipamorelin and sermorelin, and most often worked with inside supervised optimization programs. This explainer covers what CJC-1295 is, its status, and the legitimate access path.
We make no claims about what CJC-1295 does. We describe what it is, its category, and how access works.
For adults 18+. This article is educational and is not medical advice. CJC-1295 is a prescription compound that requires a licensed provider; some formulations are compounded and their regulatory status varies. Statements have not been evaluated by the FDA.
The short version
- CJC-1295 is a GH-secretagogue peptide, in the same broad category as sermorelin and ipamorelin.
- It's a prescription compound requiring a licensed provider — not over-the-counter and not a gray-market research chemical.
- It's most often worked with inside lab-first optimization programs, sometimes paired with ipamorelin.
- We make no therapeutic claims about CJC-1295 — only describe what it is and how access works.
- Some formulations are compounded and their regulatory status varies; whether it's appropriate is a clinical decision a provider makes.
Find your match
30-sec finder
Question 1 of 5
What are you here to look into?
What CJC-1295 is
CJC-1295 is a GH-secretagogue peptide — the same broad family as sermorelin and ipamorelin. That's a neutral, factual label for the category it belongs to, not a description of what it does, which we don't provide.
Its status
CJC-1295 is a prescription compound that a licensed clinician can work with, often via compounding pharmacies — not a consumer over-the-counter product and not openly-sold 'research only' material in the way an unapproved compound is. Some formulations are compounded and their regulatory status varies, so specifics depend on the provider and pharmacy.
How it's typically accessed
Like ipamorelin, CJC-1295 appears most often inside lab-first optimization programs rather than as a quick standalone item. Among the providers we list, Marek Health and Defy Medical are the ones whose physicians publicly work with it, sometimes in combination with ipamorelin, under supervision and where state and pharmacy availability allows. The path is comprehensive bloodwork, a provider evaluation, and — if appropriate — a supervised, monitored protocol.
Questions, answered
Is CJC-1295 a prescription?
Yes. CJC-1295 is a prescription GH-secretagogue compound that requires a licensed provider, often worked with via compounding pharmacies — not over-the-counter and not a gray-market research chemical. Some formulations are compounded and their regulatory status varies. This is educational information, not medical advice.
What does CJC-1295 do?
We make no claims about what CJC-1295 does. It's described in the GH-secretagogue category, a factual label, not a claim about effect. Any question about effects or appropriateness is for a licensed clinician. Statements have not been evaluated by the FDA.
Where can I get CJC-1295?
CJC-1295 is typically worked with inside lab-first optimization programs rather than as a standalone fast-start item. Among the providers we list, Marek Health and Defy Medical are the ones whose physicians publicly work with it, under supervision and where availability allows. A provider decides whether anything is appropriate after labs.
Is CJC-1295 the same as sermorelin?
No — they're different GH-secretagogue peptides in the same broad family. Sermorelin is the most widely available across the providers we list and offered as a fast-start item; CJC-1295 appears mostly inside supervised optimization programs. We make no claims about how either performs.